Rare diseases
Investigational molecules
Locations
Back to Czechia22 clinical trials in Broumov, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
CzechiaA Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
CzechiaStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
CzechiaA study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
CzechiaEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
CzechiaStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
CzechiaStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
CzechiaStudy of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications
CzechiaStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
CzechiaStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
CzechiaStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
CzechiaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on lipoprotein management and cardiovascular risk reduction in patients with established cardiovascular disease.
These trials aim to evaluate new therapeutic approaches for preventing heart attacks, strokes, and cardiovascular-related deaths.
Comprehensive studies examining innovative treatments for heart failure, particularly focusing on patients with reduced ejection fraction and kidney complications.
Research targets both efficacy and safety of novel therapeutic combinations to enhance patient outcomes.
Advanced clinical investigations into resistant hypertension management, exploring new treatment options for patients not responding to conventional therapies.
Studies focus on evaluating innovative medications for patients with difficult-to-treat high blood pressure.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
